To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RUNX3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
232 supporting clones for gene RUNX3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BC013362 Skin, melanotic melanoma. .a 1 to 2605 1 to 2605 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (37/40 A in genome downstream of last aligned base) 2605/2605
(100 %)
0 diff
(100 %id)
NM_001031680.2   .b 1 to 4340 1 to 4340 exact RefSeq,   4340/4340
(100 %)
0 diff
(100 %id)
DA935726 Spleen .b 2 to 593 2 to 593   tiling clone, capped   592/592
(100 %)
1 diff
(99.9 %id)
DB131981 thymus .b 5 to 547 2 to 545   capped   544/544
(100 %)
3 diff
(99.5 %id)
DA619685   .b 6 to 581 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DB235965 trachea .b 6 to 592 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
DA052610   .b 10 to 560 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DB164211 thymus .b 10 to 589 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
DA577267   .b 194 to 744 2 to 552   capped   551/551
(100 %)
2 diff
(99.7 %id)
AW500859 lymph .b 359 to 794 1 to 436       436/436
(100 %)
8 diff
(98.2 %id)
CF143968 lymph .b 359 to 766 1 to 408   tiling clone,   408/409
(99 %)
10 diff
(97.6 %id)
TI_154155225   .b 366 to 875 81 to 590       510/511
(99 %)
11 diff
(97.9 %id)
TI_154175684   .b 366 to 804 87 to 526       440/942
(46 %)
9 diff
(99.1 %id)
BE892336 melanotic melanoma, skin .b 368 to 1035 1 to 682       682/738
(92 %)
34 diff
(95.4 %id)
AA250967 germinal center B cell .b 485 to 764 1 to 285     Submitted on the opposite strand 285/285
(100 %)
29 diff
(89.9 %id)
AA911670 pooled .b 492 to 876 1 to 388     Submitted on the opposite strand 395/388
(101 %)
16 diff
(95.9 %id)
BM915557 amelanotic melanoma, cell line, skin .b 495 to 1361 1 to 871   tiling clone,   871/993
(87 %)
9 diff
(99.1 %id)
AA805305 germinal center B cell .b 640 to 873 1 to 232     Submitted on the opposite strand 232/232
(100 %)
9 diff
(96.2 %id)
AA290877 germinal center B cell .b 647 to 1006 360 to 1     Submitted on the opposite strand 360/360
(100 %)
8 diff
(97.8 %id)
BM917053 blood, natural killer cells, cell line .b 801 to 1861 1 to 1074       1074/1089
(98 %)
10 diff
(99.1 %id)
AA250942.
matches multiple genes
germinal center B cell .b 803 to 1233 431 to 1     Submitted on the opposite strand, also hits gene DDX20 431/431
(100 %)
2 diff
(99.6 %id)
DA944766 Spleen .b 849 to 1349 2 to 503   capped   502/502
(100 %)
1 diff
(99.9 %id)
DA972268 synovial membrane tissue from rheumatioidarthritis .b 877 to 1389 2 to 514   capped   513/513
(100 %)
0 diff
(100 %id)
BQ053509 blood, natural killer cells, cell line .b 945 to 1871 1 to 935       935/1092
(85 %)
63 diff
(94.3 %id)
BQ054372 blood, natural killer cells, cell line .b 945 to 1954 1 to 1028       1028/1055
(97 %)
32 diff
(97.0 %id)
BQ054373 blood, natural killer cells, cell line .b 945 to 1980 1 to 1053       1053/1062
(99 %)
43 diff
(96.0 %id)
BX107980 germinal center B cell .b 952 to 1735 1 to 787   tiling clone,   787/787
(100 %)
6 diff
(99.3 %id)
AW407599 lymph .b 964 to 1364 1 to 401       401/401
(100 %)
5 diff
(98.8 %id)
AA481586 germinal center B cell .b 969 to 1424 1 to 457     Possibly primed on the genome, locally A rich (37/40 A in genome downstream of last aligned base) 457/461
(99 %)
2 diff
(99.6 %id)
TI_154146180   .b 970 to 1641 73 to 741       669/809
(82 %)
41 diff
(95.0 %id)
TI_154147236   .b 970 to 1601 83 to 712       630/630
(100 %)
6 diff
(99.1 %id)
BG480446 choriocarcinoma, placenta .b 983 to 1501 1 to 518       518/518
(100 %)
6 diff
(98.9 %id)
BE731758 choriocarcinoma, placenta .b 1002 to 1787 1 to 786       786/946
(83 %)
16 diff
(98.4 %id)
BE731947 choriocarcinoma, placenta .b 1002 to 1782 1 to 782   AAA   782/890
(87 %)
17 diff
(98.1 %id)
BE732427 choriocarcinoma, placenta .b 1002 to 1746 1 to 752       752/1123
(66 %)
36 diff
(96.8 %id)
BP267475 thyroid .b 1052 to 1627 1 to 576       576/576
(100 %)
3 diff
(99.5 %id)
BP268061 thyroid .b 1052 to 1621 1 to 570       570/570
(100 %)
2 diff
(99.7 %id)
AW504450 lymph .b 1054 to 1539 8 to 493       486/493
(98 %)
6 diff
(98.8 %id)
TI_154160601   .b 1054 to 1689 81 to 714       634/712
(89 %)
12 diff
(98.4 %id)
DA585445 lung .b 1093 to 1640 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
BU431653 lymph .b 1122 to 1382 1 to 261       261/308
(84 %)
6 diff
(98.1 %id)
BU431690 lymph .b 1122 to 1382 1 to 261       261/314
(83 %)
6 diff
(98.1 %id)
BG744116 blood, natural killer cells, cell line .b 1164 to 1919 1 to 757       757/924
(81 %)
25 diff
(97.3 %id)
CR988743 T-Lymphocytes .b 1184 to 1878 1 to 695       695/695
(100 %)
0 diff
(100 %id)
BG770144 melanotic melanoma, high MDR (cell line), skin .b 1192 to 1862 1 to 674       674/674
(100 %)
4 diff
(99.5 %id)
CB270463 adipose .b 1229 to 1712 1 to 484       484/484
(100 %)
1 diff
(99.8 %id)
CR591302 B cells (Ramos cell line) Cot 25-normalized .b 1244 to 2755 1 to 1512   tiling clone,   1512/1512
(100 %)
0 diff
(100 %id)
AL582985 B cells from Burkitt lymphoma .b 1244 to 2087 1 to 827       827/881
(93 %)
31 diff
(96.5 %id)
CR997146 T-Lymphocytes .b 1345 to 1873 1 to 529       529/531
(99 %)
1 diff
(99.9 %id)
CR989291 T-Lymphocytes .b 1345 to 1956 1 to 611       611/613
(99 %)
2 diff
(99.7 %id)
BX349283   .b 1795 to 2662 1 to 869   AAA   869/992
(87 %)
66 diff
(93.4 %id)
AL582933 B cells from Burkitt lymphoma .b 1798 to 2742 932 to 14       919/962
(95 %)
0 diff
(100 %id)
AA302999   .b 1825 to 2032 1 to 208       208/208
(100 %)
0 diff
(100 %id)
AA352709   .b 1968 to 2248 1 to 281       281/284
(98 %)
1 diff
(99.7 %id)
AA355209   .b 2002 to 2346 1 to 346       346/346
(100 %)
3 diff
(99.2 %id)
FN103350 breast carcinoma .b 2051 to 2142 92 to 1     Submitted on the opposite strand 92/92
(100 %)
4 diff
(95.7 %id)
BG744781 blood, natural killer cells, cell line .b 2058 to 2746 690 to 2       689/690
(99 %)
0 diff
(100 %id)
BE707683 head_neck .b 2072 to 2359 22 to 317       296/322
(91 %)
17 diff
(94.8 %id)
BY995627   .b 2149 to 2651 1 to 503       503/503
(100 %)
1 diff
(99.9 %id)
AI282248 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 2165 to 2462 297 to 1       297/297
(100 %)
2 diff
(99.4 %id)
AA541630 normal prostate, Prostate .b 2206 to 2815 605 to 1       605/608
(99 %)
13 diff
(97.9 %id)
TI_154151569   .b 2210 to 2801 671 to 82     Submitted on the opposite strand 590/668
(88 %)
15 diff
(97.8 %id)
AW015253   .b 2231 to 2798 586 to 18   AAA Possibly primed on the genome, locally A rich (37/40 A in genome downstream of last aligned base) 569/569
(100 %)
7 diff
(98.8 %id)
BE646639 B-cell, chronic lymphotic leukemia .b 2248 to 2800 553 to 1       553/553
(100 %)
1 diff
(99.9 %id)
AL120686 melanoma (MeWo cell line) .b 2251 to 2879 1 to 629   tiling clone,   629/629
(100 %)
0 diff
(100 %id)
AA418642 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2256 to 2564 1 to 308   fully sequenced,   308/308
(100 %)
1 diff
(99.7 %id)
BE674776 B-cell, chronic lymphotic leukemia .b 2259 to 2809 551 to 1       551/551
(100 %)
2 diff
(99.7 %id)
BM504200 insulinoma, Pancreas .b 2267 to 2798 550 to 19   AAA Possibly primed on the genome, locally A rich (37/40 A in genome downstream of last aligned base) 532/532
(100 %)
1 diff
(99.9 %id)
TI_154134829   .b 2296 to 2798 600 to 98   AAA Possibly primed on the genome, locally A rich (37/40 A in genome downstream of last aligned base) 503/503
(100 %)
4 diff
(99.3 %id)
BE676155 B-cell, chronic lymphotic leukemia .b 2298 to 2800 503 to 1       503/503
(100 %)
1 diff
(99.9 %id)
AI633590 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2313 to 2811 499 to 1       499/499
(100 %)
0 diff
(100 %id)
AW170176 cervix .b 2318 to 2796 479 to 1       479/479
(100 %)
8 diff
(98.4 %id)
AI524028 B-cell, chronic lymphotic leukemia .b 2340 to 2799 460 to 1       460/460
(100 %)
0 diff
(100 %id)
BG230606 blood, lymphocyte .b 2343 to 2814 474 to 3       472/474
(99 %)
0 diff
(100 %id)
AI492090 B-cell, chronic lymphotic leukemia .b 2348 to 2814 467 to 1       467/467
(100 %)
0 diff
(100 %id)
BE677415 dorsal root ganglia .b 2354 to 2807 454 to 1       454/454
(100 %)
0 diff
(100 %id)
BE876200 large cell carcinoma, undifferentiated, lung .b 2368 to 2840 220 to 689   AAA   470/701
(67 %)
6 diff
(99.2 %id)
BE676336 B-cell, chronic lymphotic leukemia .b 2372 to 2809 436 to 1       436/436
(100 %)
2 diff
(99.6 %id)
AA627429 colon, colon tumor RER+ .b 2382 to 2798 440 to 25   AAA Possibly primed on the genome, locally A rich (37/40 A in genome downstream of last aligned base) 416/416
(100 %)
1 diff
(99.8 %id)
BU430235 lymph .b 2383 to 2801 426 to 8     Submitted on the opposite strand 419/426
(98 %)
0 diff
(100 %id)
BI031266 marrow .b 2392 to 2740 1 to 349       349/357
(97 %)
3 diff
(99.2 %id)
BI029423 marrow .b 2394 to 2740 359 to 13       347/367
(94 %)
0 diff
(100 %id)
AA847903 germinal center B cell .b 2400 to 2806 407 to 1       407/407
(100 %)
1 diff
(99.8 %id)
AA765347 germinal center B cell .b 2407 to 2822 405 to 3       403/459
(87 %)
0 diff
(100 %id)
AL561262 B cells from Burkitt lymphoma .b 2424 to 2798 1 to 375   AAA Possibly primed on the genome, locally A rich (37/40 A in genome downstream of last aligned base) 375/375
(100 %)
1 diff
(99.8 %id)
AI686121 Prostate .b 2492 to 2815 324 to 1       324/324
(100 %)
1 diff
(99.7 %id)
AI685772 Prostate .b 2492 to 2815 324 to 1       324/324
(100 %)
0 diff
(100 %id)
BF478062 Prostate .b 2492 to 2815 324 to 1       324/324
(100 %)
0 diff
(100 %id)
BF437242 Prostate .b 2492 to 2815 324 to 1       324/324
(100 %)
1 diff
(99.7 %id)
AA481280 germinal center B cell .b 2510 to 2798 347 to 59   AAA Possibly primed on the genome, locally A rich (37/40 A in genome downstream of last aligned base) 289/289
(100 %)
2 diff
(99.4 %id)
AW801875 uterus .b 2511 to 2815 14 to 316   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 303/319
(94 %)
8 diff
(97.5 %id)
BI002865 head_normal .b 2532 to 2706 207 to 37       171/207
(82 %)
0 diff
(100 %id)
AA927119 pooled .b 2533 to 2799 268 to 1       268/271
(98 %)
1 diff
(99.7 %id)
AA418580 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2534 to 2811 278 to 1   fully sequenced,   278/278
(100 %)
1 diff
(99.7 %id)
BQ431324 melanotic melanoma, skin .b 2539 to 2798 1 to 260   AAA Possibly primed on the genome, locally A rich (37/40 A in genome downstream of last aligned base) 260/260
(100 %)
0 diff
(100 %id)
BF063985 colon, colon tumor, RER+ .b 2591 to 2797 207 to 1       207/207
(100 %)
1 diff
(99.6 %id)
CD515408 White Matter .b 2592 to 2798 1 to 207   AAA Possibly primed on the genome, locally A rich (37/40 A in genome downstream of last aligned base) 207/207
(100 %)
0 diff
(100 %id)
AV711623   .b 2618 to 2821 1 to 205   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 205/209
(98 %)
7 diff
(96.7 %id)
C02403   .b 2720 to 2798 1 to 79       79/79
(100 %)
0 diff
(100 %id)
BM905051 melanotic melanoma, skin .b 2802 to 3791 1 to 1001   tiling clone,   1001/1001
(100 %)
25 diff
(97.6 %id)
T84364 liver and spleen .b 2827 to 3194 1 to 383       383/383
(100 %)
19 diff
(95.1 %id)
BQ708535 Spleen .b 2839 to 3522 1 to 688       688/861
(79 %)
11 diff
(98.8 %id)
BE280249 choriocarcinoma, placenta .b 2896 to 3549 1 to 653       653/691
(94 %)
9 diff
(98.7 %id)
BE900776 choriocarcinoma, placenta .b 2898 to 3658 1 to 749       749/962
(77 %)
29 diff
(97.0 %id)
BP339414 Spleen .b 2898 to 3477 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
BF976279 B-cells, primary B-cells from tonsils (cell line) .b 3015 to 3831 1 to 812       812/910
(89 %)
19 diff
(98.0 %id)
BF974509 B-cells, primary B-cells from tonsils (cell line) .b 3016 to 3803 1 to 795       795/888
(89 %)
16 diff
(98.2 %id)
AA354842   .b 3051 to 3274 1 to 224       224/224
(100 %)
1 diff
(99.6 %id)
CR980405 T-Lymphocytes .b 3096 to 3916 1 to 822       822/822
(100 %)
5 diff
(99.4 %id)
AA807193 germinal center B cell .b 3165 to 3297 133 to 1       133/133
(100 %)
4 diff
(97.0 %id)
BQ054185 blood, natural killer cells, cell line .b 3184 to 4026 35 to 881       847/1144
(74 %)
16 diff
(98.7 %id)
BI017269 lung_tumor .b 3209 to 3652 458 to 16       443/458
(96 %)
0 diff
(100 %id)
BI017071 lung_tumor .b 3215 to 3651 435 to 1       435/435
(100 %)
8 diff
(98.2 %id)
BQ062837 lymph, lymphoma, cell line .b 3216 to 4205 29 to 1023       995/1025
(97 %)
36 diff
(96.5 %id)
BU199150   .b 3219 to 3991 1 to 774       774/893
(86 %)
45 diff
(95.0 %id)
BQ055603 lymph, lymphoma, cell line .b 3219 to 4007 1 to 802       802/954
(84 %)
29 diff
(97.0 %id)
BQ058146 lymph, lymphoma, cell line .b 3219 to 4174 1 to 972       972/1058
(91 %)
27 diff
(97.5 %id)
AW834702 leiomios .b 3223 to 3817 1 to 589       589/597
(98 %)
18 diff
(97.0 %id)
AW834699 leiomios .b 3227 to 3807 7 to 586       580/586
(98 %)
3 diff
(99.5 %id)
AW834739 leiomios .b 3266 to 3541 10 to 288       279/289
(96 %)
16 diff
(94.5 %id)
AI766699 B-cell, chronic lymphotic leukemia .b 3267 to 3645 398 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 380/380
(100 %)
3 diff
(99.3 %id)
TI_149303170   .b 3280 to 4283 1036 to 57   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 980/985
(99 %)
31 diff
(96.9 %id)
AW167608 cervix .b 3284 to 3675 457 to 68   AAA   390/436
(89 %)
0 diff
(100 %id)
AW385290 leiomios .b 3286 to 3807 522 to 1       522/522
(100 %)
2 diff
(99.7 %id)
BU622392 cell lines, Chondrosarcoma .b 3376 to 3888 653 to 141   AAA   513/638
(80 %)
0 diff
(100 %id)
BM705361 eye, RPE and Choroid .b 3388 to 3951 1 to 564   tiling clone,   564/564
(100 %)
0 diff
(100 %id)
BP430116   .b 3414 to 3776 1 to 363       363/363
(100 %)
4 diff
(98.9 %id)
BQ429996 melanotic melanoma, skin .b 3431 to 3959 93 to 627       535/1019
(52 %)
27 diff
(97.4 %id)
T75562 liver and spleen .b 3452 to 3812 1 to 362       362/364
(99 %)
3 diff
(99.2 %id)
R02484 liver and spleen .b 3452 to 3816 1 to 370       370/402
(92 %)
7 diff
(98.3 %id)
BM981226 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 3477 to 4283 825 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 807/807
(100 %)
5 diff
(99.4 %id)
CD639915 pooled .b 3532 to 4232 1 to 699       699/701
(99 %)
8 diff
(98.9 %id)
BU624234 cell lines, Enchondroma .b 3580 to 4277 717 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 699/699
(100 %)
7 diff
(99.0 %id)
BQ016137 lung, Metastatic Chondrosarcoma .b 3596 to 4283 706 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 688/688
(100 %)
1 diff
(99.9 %id)
CA306601 Alveolar Macrophage, lung .b 3596 to 4283 703 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 685/685
(100 %)
5 diff
(99.3 %id)
CA432310 cell lines, Enchondroma .b 3613 to 4332 738 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 720/720
(100 %)
0 diff
(100 %id)
BQ774495 Chondrosarcoma Grade II, Left Pelvis .b 3647 to 4283 655 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 637/637
(100 %)
6 diff
(99.1 %id)
W94742 heart .b 3648 to 4012 1 to 370   fully sequenced,   370/370
(100 %)
1 diff
(99.8 %id)
BQ004968 Chondrosarcoma, Left Pelvis .b 3677 to 4283 625 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 607/614
(98 %)
1 diff
(99.9 %id)
W58048 heart .b 3685 to 4285 1 to 602       602/602
(100 %)
12 diff
(98.1 %id)
H48039 liver and spleen .b 3701 to 4051 1 to 363   fully sequenced,   363/363
(100 %)
6 diff
(98.4 %id)
BU734530 eye, RPE and Choroid .b 3720 to 4333 631 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 613/613
(100 %)
3 diff
(99.6 %id)
AI022631 liver and spleen .b 3780 to 4287 510 to 3       508/510
(99 %)
0 diff
(100 %id)
AI079556 liver and spleen .b 3781 to 4283 503 to 1       503/503
(100 %)
0 diff
(100 %id)
N67778 melanocyte .b 3804 to 4284 489 to 1       489/490
(99 %)
9 diff
(98.2 %id)
W58366 heart .b 3831 to 4332 509 to 3       507/511
(99 %)
0 diff
(100 %id)
AA994035 pooled .b 3837 to 4283 447 to 1       447/447
(100 %)
1 diff
(99.8 %id)
AI763391 B-cell, chronic lymphotic leukemia .b 3842 to 4340 501 to 3       499/501
(99 %)
0 diff
(100 %id)
AI081392 senescent fibroblast .b 3856 to 4283 441 to 14   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 428/428
(100 %)
1 diff
(99.8 %id)
BM669083 eye, RPE and Choroid .b 3875 to 4333 477 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 459/459
(100 %)
2 diff
(99.6 %id)
AA831205 germinal center B cell .b 3876 to 4331 467 to 12   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 456/456
(100 %)
1 diff
(99.8 %id)
AW276069 lung, two pooled squamous cell carcinomas .b 3876 to 4286 411 to 1       411/411
(100 %)
0 diff
(100 %id)
AW304478 pooled .b 3877 to 4273 408 to 12   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 397/397
(100 %)
0 diff
(100 %id)
BE676487 B-cell, chronic lymphotic leukemia .b 3879 to 4283 428 to 24   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 405/405
(100 %)
3 diff
(99.3 %id)
AI028486 B-cell, chronic lymphotic leukemia .b 3883 to 4332 472 to 23   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 450/450
(100 %)
4 diff
(99.2 %id)
AI190678 heart .b 3887 to 4335 449 to 1       449/449
(100 %)
1 diff
(99.8 %id)
AW469656 pooled .b 3891 to 4333 443 to 1       443/461
(96 %)
3 diff
(99.4 %id)
AI075058 breast .b 3920 to 4329 410 to 1       410/410
(100 %)
0 diff
(100 %id)
AI092506 heart .b 3920 to 4285 366 to 1       366/366
(100 %)
0 diff
(100 %id)
AI146758 B-cell, chronic lymphotic leukemia .b 3921 to 4332 413 to 2       412/413
(99 %)
0 diff
(100 %id)
AI439048 B-cell, chronic lymphotic leukemia .b 3921 to 4332 414 to 3       412/414
(99 %)
0 diff
(100 %id)
AI274405 adenocarcinoma, colon .b 3922 to 4287 368 to 3       366/368
(99 %)
0 diff
(100 %id)
AI243868 pooled .b 3923 to 4287 365 to 1       365/365
(100 %)
4 diff
(99.0 %id)
AI375031   .b 3931 to 4340 413 to 4   tiling clone,   410/413
(99 %)
0 diff
(100 %id)
AA621259   .b 3935 to 4332 414 to 17   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 398/398
(100 %)
1 diff
(99.8 %id)
AI866783 brain, tumor, 5 pooled (see description) .b 3947 to 4287 345 to 5       341/345
(98 %)
0 diff
(100 %id)
AV736356 cord Blood .b 3948 to 4281 1 to 323   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 323/325
(99 %)
7 diff
(97.9 %id)
AA809959 germinal center B cell .b 3950 to 4334 419 to 35   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 385/385
(100 %)
0 diff
(100 %id)
AI636867 Kidney, renal cell tumor .b 3952 to 4284 333 to 1       333/333
(100 %)
0 diff
(100 %id)
R00132 liver and spleen .b 3960 to 4281 327 to 1       327/361
(90 %)
14 diff
(96.2 %id)
AI760829 B-cell, chronic lymphotic leukemia .b 3962 to 4332 393 to 23   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 371/371
(100 %)
17 diff
(95.5 %id)
AA693562 liver and spleen .b 3965 to 4283 319 to 1       319/319
(100 %)
1 diff
(99.7 %id)
AA312733   .b 3969 to 4283 1 to 315       315/315
(100 %)
0 diff
(100 %id)
AW951046   .b 3970 to 4283 1 to 314   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 314/314
(100 %)
0 diff
(100 %id)
W94743 heart .b 3982 to 4332 355 to 1   fully sequenced,   355/355
(100 %)
0 diff
(100 %id)
AA912790 pooled .b 3989 to 4334 346 to 1       346/346
(100 %)
0 diff
(100 %id)
AI131365 heart .b 3989 to 4286 298 to 1       298/298
(100 %)
0 diff
(100 %id)
AI247809 liver and spleen .b 4002 to 4335 335 to 1       335/335
(100 %)
1 diff
(99.8 %id)
AI475667 B-cell, chronic lymphotic leukemia .b 4007 to 4332 328 to 3       326/328
(99 %)
0 diff
(100 %id)
AI475706 B-cell, chronic lymphotic leukemia .b 4007 to 4332 328 to 3       326/328
(99 %)
0 diff
(100 %id)
H48040 liver and spleen .b 4021 to 4322 304 to 1   fully sequenced,   304/304
(100 %)
1 diff
(99.7 %id)
AA737037 germinal center B cell .b 4032 to 4283 265 to 12   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 254/254
(100 %)
5 diff
(98.1 %id)
AI691099 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 4032 to 4279 253 to 5       249/253
(98 %)
0 diff
(100 %id)
AW015682   .b 4032 to 4292 264 to 4       261/275
(94 %)
0 diff
(100 %id)
AW137952   .b 4032 to 4283 264 to 13   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 252/263
(95 %)
0 diff
(100 %id)
AA845770 Spleen .b 4050 to 4287 239 to 2       238/239
(99 %)
0 diff
(100 %id)
AI248006 liver and spleen .b 4060 to 4335 276 to 1       276/276
(100 %)
0 diff
(100 %id)
R02377 liver and spleen .b 4086 to 4287 205 to 3       203/205
(99 %)
0 diff
(100 %id)
BI021239 marrow .b 4143 to 4289 148 to 1       148/148
(100 %)
3 diff
(98.0 %id)
FN104061 breast carcinoma .b 4179 to 4248 72 to 1     Submitted on the opposite strand 72/72
(100 %)
2 diff
(97.3 %id)
AA928354 adenocarcinoma, colon .b 4206 to 4332 128 to 2       127/128
(99 %)
0 diff
(100 %id)
NM_004350.2   .c 1 to 4270 1 to 4270 exact RefSeq,   4270/4270
(100 %)
0 diff
(100 %id)
AJ001432   .c 2 to 411 1 to 410   tiling clone,   410/410
(100 %)
2 diff
(99.6 %id)
AI122694 B-cell, chronic lymphotic leukemia .c 168 to 625 1 to 458   tiling clone, Submitted on the opposite strand 458/458
(100 %)
1 diff
(99.8 %id)
AI216386 pooled .c 177 to 722 1 to 545     Submitted on the opposite strand 545/545
(100 %)
12 diff
(97.8 %id)
CT001776 T-Lymphocytes .c 295 to 606 312 to 1     Submitted on the opposite strand 312/315
(99 %)
2 diff
(99.4 %id)
BI907760 leukocyte .c 333 to 393 1 to 58       58/64
(90 %)
3 diff
(95.4 %id)
CR980647 T-Lymphocytes .c 356 to 952 1 to 598       598/608
(98 %)
4 diff
(99.4 %id)
Z35278   .c 403 to 4214 1 to 3809 exact tiling clone,   3809/3809
(100 %)
6 diff
(99.9 %id)
X79550   .c 406 to 2204 1 to 1799 exact     1799/1806
(99 %)
1 diff
(100.0 %id)
AI475590 B-cell, chronic lymphotic leukemia .c 414 to 486 1 to 73       73/73
(100 %)
1 diff
(98.7 %id)
AK300056   .d 1 to 1392 1 to 1392 I222T A306P tiling clone,   1392/1392
(100 %)
3 diff
(99.8 %id)
DC378837   .d 1 to 555 1 to 556       556/558
(99 %)
2 diff
(99.7 %id)
AK310945 trachea .e 1 to 1656 6 to 1661 I18N tiling clone,   1661/1661
(100 %)
1 diff
(100.0 %id)
DA905630   .f 1 to 561 2 to 562   tiling clone, capped   561/561
(100 %)
1 diff
(99.9 %id)
BI912353 leukocyte .f 537 to 1149 22 to 640   tiling clone,   619/752
(82 %)
27 diff
(96.5 %id)
TI_57235560   .f 537 to 1149 22 to 640       619/752
(82 %)
27 diff
(96.5 %id)
TI_57234813   .g 1 to 808 22 to 832 G2I R7A A8P G9A R10A ... tiling clone,   811/837
(96 %)
27 diff
(96.8 %id)
BM452603 lymph, lymphoma, cell line .g 540 to 1106 1 to 567   tiling clone,   567/1144
(49 %)
14 diff
(98.8 %id)
BX485303   .g 679 to 1337 1 to 660   tiling clone,   660/660
(100 %)
3 diff
(99.6 %id)
DC390217 Spleen .h 1 to 568 1 to 570 R49X M51H A52G S53I N54E ... tiling clone,   570/570
(100 %)
7 diff
(98.8 %id)
AF022726   .h 43 to 326 1 to 284   tiling clone,   284/284
(100 %)
0 diff
(100 %id)
BI908613 leukocyte .i 1 to 572 1 to 572 exact tiling clone,   572/572
(100 %)
0 diff
(100 %id)
TI_57234922   .i 1 to 572 36 to 607 exact     572/607
(94 %)
6 diff
(99.1 %id)
DA585933 lung .j-u -11 to 500 2 to 513   tiling clone, capped   512/512
(100 %)
0 diff
(100 %id)
DA585864 lung .j-u 1 to 549 2 to 550   tiling clone, capped   549/549
(100 %)
1 diff
(99.9 %id)
DB149387 thymus .j-u 29 to 512 2 to 485   capped   484/484
(100 %)
0 diff
(100 %id)
BG762731 melanotic melanoma, high MDR (cell line), skin .j-u 1168 to 1755 1 to 586   tiling clone,   586/586
(100 %)
3 diff
(99.5 %id)
DB319407 lung .j-u 2569 to 2858 290 to 1   tiling clone,   290/290
(100 %)
1 diff
(99.7 %id)
DC391185 Spleen .k 1 to 553 1 to 557 A2G G3R N4Q D5* tiling clone,   557/557
(100 %)
4 diff
(99.3 %id)
EF491807   .l 1 to 218 1 to 218   tiling clone,   218/218
(100 %)
0 diff
(100 %id)
EF491822   .l 63 to 280 1 to 218   tiling clone,   218/218
(100 %)
0 diff
(100 %id)
DA619426   .m 1 to 261 2 to 262 exact tiling clone, capped   261/266
(98 %)
1 diff
(99.7 %id)
AK091829 lung Gene RUNX3, variant not shown       available from FLJ, AAA      
AK301044 Spleen Gene RUNX3, variant not shown         Suspected internal deletion, this clone was ignored    
AX747207   Gene RUNX3, variant not shown       AAA      
BG960657 colon Gene RUNX3, variant not shown         This clone was ignored    
BG961017 colon Gene RUNX3, variant not shown         This clone was ignored    
BG961682 colon Gene RUNX3, variant not shown         This clone was ignored    
BM504423 insulinoma, Pancreas Gene RUNX3, variant not shown         Suspected internal deletion, this clone was ignored    
AA770363 pooled Gene RUNX3, variant not shown         Suspected internal deletion, this clone was ignored    
CK905482 insulinoma, Pancreas Gene RUNX3, variant not shown         Suspected internal deletion, this clone was ignored    
CK905483 insulinoma, Pancreas Gene RUNX3, variant not shown         Suspected internal deletion, this clone was ignored    
DA813558   Gene RUNX3, variant not shown       capped Suspected internal deletion, this clone was ignored    
DC389124 Spleen Gene RUNX3, variant not shown         Suspected internal deletion, this clone was ignored    
DC391829 Spleen Gene RUNX3, variant not shown         Suspected internal deletion, this clone was ignored    
DB135927 thymus Gene RUNX3, variant not shown       capped This clone was ignored    
DB344987 thymus Gene RUNX3, variant not shown         This clone was ignored    
DB149173 thymus Gene RUNX3, variant not shown       capped This clone was ignored    
DB345985 thymus Gene RUNX3, variant not shown         This clone was ignored    
AU077133   Gene RUNX3, variant not shown         Suspected internal deletion, this clone was ignored    
AU100226   Gene RUNX3, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k, .l, .m Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI